MediSpend strengthens Governance, Risk and Compliance Solutions through Acquisition of Real Life Sciences
Acquiring Company
MediSpend
Acquired Company
Real Life Sciences
PortsmouthWayneBiotechnologySoftwareInformation TechnologyBiotechnologyHealth CareLife ScienceDescription
MediSpend, a global technology company providing best-in-class solutions for the life sciences industry, has announced its acquisition of Real Life Sciences (RLS), a leader in advanced anonymization solutions for clinical trial and other data. This strategic acquisition reinforces MediSpend's commitment to expanding its presence and capabilities in the Governance, Risk and Compliance (GRC) space, enabling clients to manage compliance and regulations comprehensively from commercial operations to research and development (R&D).
Quick answer
MediSpend is acquiring Real Life Sciences, announced January 27, 2025. MediSpend is based in Portsmouth, New Hampshire, United States.
- How much did MediSpend pay for Real Life Sciences?
- The deal value was not disclosed.
- What does MediSpend do?
- MediSpend is a global technology company providing best-in-class solutions that empower life sciences companies to grow their business compliantly through top-rated software and client services.
- Where are MediSpend and Real Life Sciences based?
- MediSpend is based in Portsmouth, New Hampshire, United States. Real Life Sciences is based in Wayne, Pennsylvania, United States.
- Who are the decision-makers at MediSpend?
- Fundz holds 1 contact at MediSpend. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Life Science and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- ActiGraph completes acquisition of Biofourmis Connect to enhance digital health solutions (January 7, 2025)
- Novo Holdings completes acquisition of Catalent, Inc. (December 18, 2024)
- Gleamer acquires Pixyl and Caerus Medical (March 11, 2025)
- GSK completes acquisition of IDRx, Inc. to enhance precision therapeutics for treating gastrointestinal stromal tumours (February 24, 2025)
- Flourish Research acquires Diablo Clinical Research to expand therapeutic coverage (February 18, 2025)
- Novartis to acquire Anthos Therapeutics for up to $3.1 Billion, $3.1B (February 11, 2025)
Who to call at MediSpend, and when
When MediSpend changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day MediSpend raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at MediSpend, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at MediSpend. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment MediSpend makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Real Life Sciences?
Real Life Sciences was acquired by MediSpend, based in Portsmouth. The deal was reported on January 27, 2025. MediSpend is a global technology company providing best-in-class solutions that empower life sciences companies to grow their business compliantly through top-rated software and client services. MediSpend is privately held and operates in Biotechnology.
When did MediSpend acquire Real Life Sciences?
MediSpend's acquisition of Real Life Sciences was reported on January 27, 2025. MediSpend, a global technology company providing best-in-class solutions for the life sciences industry, has announced its acquisition of Real Life Sciences (RLS), a leader in advanced anonymization solutions for clinical trial and other data. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Real Life Sciences do?
Real Life Sciences is a leading provider of advanced anonymization and redaction solutions for clinical trial data and other sensitive information. It is privately held, operating in Information Technology, and is based in Wayne.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.